Get the Stockscreener App
8.42
4.04%
0.25
Oric Pharmaceuticals Inc Stock (ORIC) Forecast
The Oric Pharmaceuticals Inc (ORIC) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $8.8371, representing a +4.95% increase from the current price of $8.42. The highest analyst price target is $12.51, and the lowest is $5.1635.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ORIC Price Target
Average 6.9714
(-17.20% Downside)
Is Oric Pharmaceuticals Inc (ORIC) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 75.08 | Sell |
| STOCH(9,6) | 82.14 | Sell |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | 0.597 | Buy |
| ADX(14) | 25.16 | Buy |
| William %R | -15.27 | Sell |
| CCI(14) | 206.99 | Buy |
Buy: 3
Sell: 4
Neutral: 0
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
6.5595
Buy
|
6.8857
Buy
|
| MA20 |
5.8245
Buy
|
6.247
Buy
|
| MA50 |
5.5714
Buy
|
6.1535
Buy
|
| MA100 |
7.3306
Buy
|
6.8748
Buy
|
| MA200 |
8.3909
Buy
|
7.9406
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, ORIC could be considered a Strong Buy, with 17 technical analysis indicators signaling 13 Buy signals, 4 signaling Sell signals and 0 Neutral signals. This might be a good time to open fresh positions on ORIC, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 75.08 indicates that ORIC is overbought. This suggests that ORIC price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 82.14 indicates that ORIC is oversold. This means that ORIC price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that ORIC is oversold. This suggests that ORIC price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 25.16 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 206.99 indicates that ORIC is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term ORIC price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Oric Pharmaceuticals Inc financial reports and earnings history, Oric Pharmaceuticals Inc (ORIC) stock could reach $5.6724 by 2030, $37.75 by 2040 and $57.41 by 2050. See the projected annual prices until 2050 of the Oric Pharmaceuticals Inc stock below:
- Oric Pharmaceuticals Inc (ORIC) is expected to reach an average price of $14.78 in 2035, with a high prediction of $15.07 and a low estimate of $14.96. This indicates an $75.59% rise from the last recorded price of $8.42.
- Oric Pharmaceuticals Inc (ORIC) stock is projected to chart a bullish course in 2040, with an average price target of $37.79, representing an $348.82% surge from its current level. The forecast ranges from a conservative $36.03 to a sky-high $37.75.
- Our analysts predict Oric Pharmaceuticals Inc (ORIC) to jump 500.28% by 2045, soaring from $51.30 to an average price of $50.54, potentially reaching $51.85. While $51.30 is the low estimate, the potential upside is significant.
- Oric Pharmaceuticals Inc (ORIC) stock is expected to climb by 2050, reaching an average of $57.27, a $580.11% jump from its current level. However, a wide range of estimates exists, with high and low targets of $57.41 and $57.43, respectively, highlighting the market's uncertainty.
Oric Pharmaceuticals Inc Stock (ORIC) Year by Year Forecast
Oric Pharmaceuticals Inc Stock (ORIC) Price Forecast for 2025
Oric Pharmaceuticals Inc Stock (ORIC) is expected to reach an average price of $13.44 in 2025, with a high prediction of $26.08 and a low estimate of $0.80. This indicates an +59.63% rise from the last recorded price of $8.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $5.7885 | $5.1635 | $12.51 | -31.25% |
| August, 2025 | $4.234 | $3.464 | $8.7224 | -49.71% |
| September, 2025 | $3.9695 | $3.4695 | $7.2157 | -52.86% |
| October, 2025 | $9.439 | $2.4773 | $9.589 | +12.10% |
| November, 2025 | $12.33 | $8.2529 | $13.81 | +46.49% |
| December, 2025 | $3.5739 | $0.80 | $12.64 | -57.55% |
Oric Pharmaceuticals Inc Stock (ORIC) Price Forecast for 2026
The predicted value for Oric Pharmaceuticals Inc (ORIC) in 2026 is set at an average of $4.1562. Estimates vary from a peak of $8.1841 to a trough of $0.1282, indicating an -50.64% surge from the present price of $8.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $5.1294 | $1.3117 | $6.0894 | -39.08% |
| February, 2026 | $1.795 | $0.41 | $5.5433 | -78.68% |
| March, 2026 | $2.5605 | $0.9473 | $5.0766 | -69.59% |
| April, 2026 | $2.0301 | $0.1282 | $4.6644 | -75.89% |
| May, 2026 | $3.6246 | $3.3011 | $3.4246 | -56.95% |
| June, 2026 | $4.789 | $4.0007 | $4.359 | -43.12% |
| July, 2026 | $6.8496 | $5.9074 | $6.3396 | -18.65% |
| August, 2026 | $8.3641 | $7.7457 | $8.1841 | -0.66% |
| September, 2026 | $6.7247 | $7.4847 | $7.5063 | -20.13% |
| October, 2026 | $6.3792 | $6.4442 | $6.7608 | -24.24% |
| November, 2026 | $6.9436 | $6.4853 | $6.4436 | -17.53% |
| December, 2026 | $6.9242 | $6.0059 | $6.0742 | -17.76% |
Oric Pharmaceuticals Inc Stock (ORIC) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Oric Pharmaceuticals Inc (ORIC) is $3.8965, with a high forecast of $7.2104 and a low forecast of $0.5826. This indicates an -53.72% decrease from the last price of $8.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $6.8087 | $6.9465 | $6.7003 | -19.14% |
| February, 2027 | $7.4032 | $7.1248 | $6.9932 | -12.08% |
| March, 2027 | $5.3637 | $6.9937 | $7.2104 | -36.30% |
| April, 2027 | $6.4582 | $6.1771 | $5.726 | -23.30% |
| May, 2027 | $3.8127 | $4.0127 | $5.8858 | -54.72% |
| June, 2027 | $3.5233 | $3.6048 | $3.2288 | -58.16% |
| July, 2027 | $4.6377 | $4.2894 | $4.3816 | -44.92% |
| August, 2027 | $3.6322 | $4.5922 | $4.43 | -56.86% |
| September, 2027 | $3.5028 | $3.1406 | $3.1928 | -58.40% |
| October, 2027 | $3.4673 | $3.5173 | $3.3489 | -58.82% |
| November, 2027 | $2.1117 | $3.0716 | $3.3484 | -74.92% |
| December, 2027 | $0.4777 | $0.5826 | $1.5279 | -94.33% |
Oric Pharmaceuticals Inc Stock (ORIC) Price Forecast for 2028
In 2028, Oric Pharmaceuticals Inc (ORIC) is projected to reach an average price of $5.1723, with a high projection of $10.26 and a low estimate of $0.0854. This indicates an -38.57% fall from the last price of $8.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.8732 | $0.0854 | $1.1632 | -89.63% |
| February, 2028 | $1.5287 | $0.3528 | $1.6887 | -81.84% |
| March, 2028 | $1.0819 | $0.2096 | $2.0806 | -87.15% |
| April, 2028 | $0.6563 | $1.1863 | $1.6216 | -92.21% |
| May, 2028 | $0.7631 | $0.1169 | $0.8731 | -90.94% |
| June, 2028 | $1.9186 | $0.557 | $2.5947 | -77.21% |
| July, 2028 | $3.2341 | $1.0203 | $3.3641 | -61.59% |
| August, 2028 | $4.6836 | $2.978 | $6.8536 | -44.38% |
| September, 2028 | $8.5991 | $3.4374 | $10.26 | +2.13% |
| October, 2028 | $4.7546 | $4.6946 | $9.243 | -43.53% |
| November, 2028 | $3.2168 | $1.5363 | $4.8974 | -61.80% |
| December, 2028 | $0.3567 | $6.2267 | $6.03 | -95.76% |
Oric Pharmaceuticals Inc Stock (ORIC) Price Forecast for 2029
The 2029 price forecast for Oric Pharmaceuticals Inc Stock (ORIC) is $5.7639 on average, with a high prediction of $11.44 and a low estimate of $0.0894. This represents an -31.55% decrease from the previous price of $8.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.3621 | $1.6579 | $6.7044 | -83.82% |
| February, 2029 | $1.8968 | $0.6854 | $8.6676 | -77.47% |
| March, 2029 | $11.34 | $8.1491 | $7.0858 | +34.63% |
| April, 2029 | $6.7047 | $6.8002 | $5.9747 | -20.37% |
| May, 2029 | $10.93 | $7.1468 | $9.7759 | +29.76% |
| June, 2029 | $5.7448 | $8.6826 | $5.2531 | -31.77% |
| July, 2029 | $6.0838 | $8.8538 | $7.2693 | -27.75% |
| August, 2029 | $3.5951 | $1.2895 | $8.2873 | -57.30% |
| September, 2029 | $2.0661 | $1.3075 | $11.44 | -75.46% |
| October, 2029 | $4.235 | $0.0894 | $10.43 | -49.70% |
| November, 2029 | $2.166 | $1.256 | $8.5082 | -74.28% |
| December, 2029 | $4.8329 | $3.2662 | $3.0807 | -42.60% |
Oric Pharmaceuticals Inc Stock (ORIC) Price Forecast for 2030
Oric Pharmaceuticals Inc Stock (ORIC) is expected to reach an average price of $8.6201 in 2030, with a high forecast of $15.17 and a low forecast of $2.071. This signifies an +2.38% surge from the last price of $8.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.7341 | $4.5819 | $5.6724 | -55.65% |
| February, 2030 | $7.843 | $4.0586 | $3.543 | -6.85% |
| March, 2030 | $9.222 | $8.0853 | $7.532 | +9.52% |
| April, 2030 | $9.3109 | $8.8987 | $8.4542 | +10.58% |
| May, 2030 | $3.6221 | $7.3821 | $9.1254 | -56.98% |
| June, 2030 | $0.551 | $2.071 | $2.0543 | -93.46% |
| July, 2030 | $9.0922 | $2.7533 | $8.4922 | +7.98% |
| August, 2030 | $7.3612 | $9.1812 | $9.8417 | -12.58% |
| September, 2030 | $10.52 | $8.8484 | $9.8701 | +24.94% |
| October, 2030 | $9.8613 | $9.659 | $9.1746 | +17.12% |
| November, 2030 | $13.95 | $11.92 | $13.91 | +65.68% |
| December, 2030 | $15.37 | $15.13 | $15.17 | +82.53% |
1.76%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):